Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 55151-55200 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT04591990
HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome
PHASE3
Recruiting
380 participants
Started: May 27, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
14 locations
NCT04979728
HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots
N/A
Recruiting
150 participants
Started: May 27, 2021 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT04720339
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
NA
Recruiting
250 participants
Started: May 27, 2021 · Completed: Oct 27, 2027
3 conditions
1 sponsor
8 locations
NCT04581109
Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP)
NA
Recruiting
100 participants
Started: May 27, 2021 · Completed: Oct 31, 2025
1 condition
1 sponsor
2 locations
NCT04579991
Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal Women
NA
Recruiting
100 participants
Started: May 27, 2021 · Completed: Nov 25, 2024
3 conditions
1 sponsor
1 location
NCT04993469
Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery
NA
Recruiting
200 participants
Started: May 27, 2021 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT04903314
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
PHASE1
Recruiting
24 participants
Started: May 27, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
14 locations
NCT04141878
Dementia and Diabetes Prevention Program
NA
Recruiting
400 participants
Started: May 26, 2021 · Completed: Jun 27, 2025
2 conditions
3 sponsors
1 location
NCT06206096
PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC
PHASE2
Recruiting
40 participants
Started: May 26, 2021 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT04870762
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
PHASE2
Recruiting
119 participants
Started: May 26, 2021 · Completed: Dec 31, 2026
7 conditions
1 sponsor
7 locations
NCT04637763
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
PHASE1
Recruiting
72 participants
Started: May 26, 2021 · Completed: Sep 30, 2025
7 conditions
1 sponsor
38 locations
NCT04785196
APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
95 participants
Started: May 26, 2021 · Completed: Jan 31, 2027
2 conditions
2 sponsors
3 locations
NCT04805762
Your COACH Next Door Study
N/A
Recruiting
1,300 participants
Started: May 26, 2021 · Completed: Sep 1, 2026
1 condition
1 sponsor
1 location
NCT04368806
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis
PHASE2/PHASE3
Recruiting
140 participants
Started: May 26, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
9 locations
NCT06607445
"Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program MedeA in the Extremadura Health Service."
N/A
Recruiting
6,445 participants
Started: May 26, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04550377
Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI
PHASE2
Recruiting
120 participants
Started: May 26, 2021 · Completed: Jun 30, 2026
2 conditions
2 sponsors
1 location
NCT04789915
Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis
PHASE1
Recruiting
46 participants
Started: May 26, 2021 · Completed: Dec 31, 2026
2 conditions
3 sponsors
1 location
NCT06176183
A Comparative Prospective Study of the Arthroscopic Meniscal Repair Methods
NA
Recruiting
100 participants
Started: May 26, 2021 · Completed: Dec 26, 2026
3 conditions
2 sponsors
2 locations
NCT04938297
Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma
PHASE2
Recruiting
100 participants
Started: May 26, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT07006675
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
PHASE3
Recruiting
1,000 participants
Started: May 26, 2021 · Completed: Mar 31, 2027
2 conditions
2 sponsors
14 locations
NCT04627870
ACOART Intracranial ISR Pilot:Intracranial DCB in the Treatment of Intracranial In-stent Restenosis
NA
Recruiting
20 participants
Started: May 26, 2021 · Completed: Dec 30, 2025
2 conditions
2 sponsors
1 location
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
PHASE3
Recruiting
150 participants
Started: May 26, 2021 · Completed: Dec 31, 2030
4 conditions
1 sponsor
60 locations
NCT04917887
Long-Term Follow-up Protocol
N/A
Recruiting
50 participants
Started: May 25, 2021 · Completed: May 25, 2028
3 conditions
1 sponsor
3 locations
NCT04892693
Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency
PHASE2
Recruiting
70 participants
Started: May 25, 2021 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT05444907
Deep Brain Stimulation-Induced Mania in Parkinson's Disease
N/A
Recruiting
100 participants
Started: May 25, 2021 · Completed: Dec 31, 2025
2 conditions
5 sponsors
1 location
NCT04850729
Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer.
N/A
Recruiting
169 participants
Started: May 25, 2021 · Completed: Apr 1, 2026
2 conditions
1 sponsor
1 location
NCT04905745
The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy
N/A
Recruiting
100 participants
Started: May 25, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT07198217
Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient
PHASE2
Recruiting
20 participants
Started: May 25, 2021 · Completed: Oct 10, 2027
4 conditions
1 sponsor
1 location
NCT05207943
Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries
NA
Recruiting
40 participants
Started: May 25, 2021 · Completed: Dec 25, 2025
1 condition
1 sponsor
1 location
NCT05893186
Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder
EARLY_PHASE1
Recruiting
60 participants
Started: May 25, 2021 · Completed: Jul 15, 2027
1 condition
1 sponsor
1 location
NCT04792489
DALY II USA/ MB-CART2019.1 for DLBCL
PHASE2
Recruiting
248 participants
Started: May 25, 2021 · Completed: Dec 31, 2028
8 conditions
1 sponsor
25 locations
NCT04895241
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
PHASE3
Recruiting
540 participants
Started: May 25, 2021 · Completed: Mar 16, 2027
1 condition
1 sponsor
169 locations
NCT04379973
Live Birth After Additional Tubal Flushing With Oil-based Contrast Versus no Additional Flushing:
PHASE4
Recruiting
736 participants
Started: May 25, 2021 · Completed: Dec 1, 2025
1 condition
1 sponsor
16 locations
NCT04236128
Home to Stay Mobile App for Colorectal Surgery
NA
Recruiting
670 participants
Started: May 25, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04945603
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
N/A
Recruiting
800 participants
Started: May 25, 2021 · Completed: Dec 31, 2028
2 conditions
10 sponsors
10 locations
NCT06466265
Study of DNP002 in Patients With Solid Tumors
PHASE1
Recruiting
36 participants
Started: May 24, 2021 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT04609046
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
PHASE1
Recruiting
47 participants
Started: May 24, 2021 · Completed: May 31, 2026
1 condition
1 sponsor
52 locations
NCT04771130
A Study of BGB-11417 in Participants With Myeloid Malignancies
PHASE1/PHASE2
Recruiting
260 participants
Started: May 24, 2021 · Completed: Feb 8, 2028
3 conditions
1 sponsor
49 locations
NCT05127265
Pervasive Sensing and AI in Intelligent ICU
N/A
Recruiting
400 participants
Started: May 24, 2021 · Completed: Dec 31, 2026
4 conditions
3 sponsors
1 location
NCT04573231
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
PHASE2
Recruiting
13 participants
Started: May 24, 2021 · Completed: Nov 30, 2025
3 conditions
1 sponsor
1 location
NCT04849455
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
PHASE4
Recruiting
70 participants
Started: May 24, 2021 · Completed: May 1, 2023
4 conditions
1 sponsor
1 location
NCT04809025
Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer
N/A
Recruiting
510 participants
Started: May 24, 2021 · Completed: Sep 1, 2026
4 conditions
1 sponsor
1 location
NCT04139304
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
EARLY_PHASE1
Recruiting
15 participants
Started: May 24, 2021 · Completed: Jul 31, 2030
5 conditions
7 sponsors
8 locations
NCT05774847
Unconscious Processing in Decision-making
N/A
Recruiting
200 participants
Started: May 24, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04741997
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
EARLY_PHASE1
Recruiting
50 participants
Started: May 24, 2021 · Completed: Jul 31, 2026
3 conditions
2 sponsors
1 location
NCT04774393
Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2
Recruiting
84 participants
Started: May 24, 2021 · Completed: Nov 29, 2025
3 conditions
1 sponsor
1 location
NCT04349826
The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)
PHASE4
Recruiting
2,150 participants
Started: May 23, 2021 · Completed: Sep 30, 2025
1 condition
5 sponsors
1 location
NCT04804943
Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome)
NA
Recruiting
45 participants
Started: May 22, 2021 · Completed: Sep 4, 2025
1 condition
1 sponsor
1 location
NCT04790682
LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG
NA
Recruiting
300 participants
Started: May 22, 2021 · Completed: Jun 3, 2030
1 condition
1 sponsor
3 locations
NCT04445571
Surfactant Administration by Insure or Thin Catheter
NA
Recruiting
160 participants
Started: May 21, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
Previous
1
More pages
1101
1102
1103
1104
1105
1106
1107
More pages
1333
Next